학술논문
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis
Document Type
Article
Author
Source
In: Biomedicine and Pharmacotherapy . (Biomedicine and Pharmacotherapy, December 2023, 168)
Subject
Language
English
ISSN
19506007
07533322
07533322